Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning ; volume:14 ; number:1 ; day:24 ; month:2 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (24.2.2024), 1-13, 12.2024
- Urheber
-
Petch, Jeremy
Nelson, Walter
Wu, Mary
Ghassemi, Marzyeh
Benz, Alexander
Fatemi, Mehdi
Di, Shuang
Carnicelli, Anthony
Granger, Christopher
Giugliano, Robert
Hong, Hwanhee
Patel, Manesh
Wallentin, Lars
Eikelboom, John
Connolly, Stuart J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-55110-9
- URN
-
urn:nbn:de:101:1-2405020842364.400038543374
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Petch, Jeremy
- Nelson, Walter
- Wu, Mary
- Ghassemi, Marzyeh
- Benz, Alexander
- Fatemi, Mehdi
- Di, Shuang
- Carnicelli, Anthony
- Granger, Christopher
- Giugliano, Robert
- Hong, Hwanhee
- Patel, Manesh
- Wallentin, Lars
- Eikelboom, John
- Connolly, Stuart J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The use of warfarin in veterans with atrial fibrillation
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Systematic Review of Pharmacogenetic Warfarin Dosing
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance
The use of warfarin in veterans with atrial fibrillation
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Systematic Review of Pharmacogenetic Warfarin Dosing
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance
The use of warfarin in veterans with atrial fibrillation
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Systematic Review of Pharmacogenetic Warfarin Dosing
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?